Connection Capital, a specialist private client alternative investments business, saw its highest ever levels of demand from private investor clients for alternative asset investments last year, raising a record GBP77 million of private capital across its direct private equity and debt transactions and third party managed alternative fund opportunities, in 2021.
Connection Capital clients demonstrated plenty of appetite for direct private equity deals, which included supporting the MBO of fast-growing UK pharmacy group, Pickford’s Pharmacies, and investing in MatOrtho, a specialist UK manufacturer of orthopaedic implants.
Private client investors of Connection Capital were also more likely than in previous years to invest in alternative funds, suggesting a desire to spread risk more widely across a broader portfolio of assets. Two-thirds (66 per cent) of the funds raised were committed to alternative asset funds and co-investments.
